Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Apexigen, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Apexigen, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wong Amy | SVP, Finance and Operations | 0 | Aug 25, 2023 | 0 |
| Sarena Francis Willard | President and COO | 0 | Aug 25, 2023 | 0 |
| Duke William E. | Chief Financial Officer | 0 | Aug 25, 2023 | 0 |
| Yang Xiaodong | Chief Executive Officer | 0 | Aug 25, 2023 | 0 |
| Ringold Gordon | Director | 0 | Aug 25, 2023 | 0 |
| Cross Herb | Director | – | Aug 25, 2023 | 0 |
| Wertheimer Samuel P | Director | 0 | Aug 25, 2023 | 0 |
| Chhabra Meenu | Director | – | Aug 25, 2023 | 0 |
| Dupont Jakob | Director | – | Aug 25, 2023 | 0 |
| Smith Scott Andrew | Director | – | Aug 25, 2023 | 0 |
| Hsu Frank J. | Chief Medical Officer | 0 | Aug 25, 2023 | 0 |
| Zabrowksi Dan | Director | – | Aug 25, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.